Shinobi Therapeutics

South San Francisco, CA · Founded 2015 · Privately Held (backing)

Developer of cell therapies designed for comprehensive immune evasion. Shinobi Therapeutics is based in South San Francisco, CA and was founded in 2015. It has raised $78.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$78.3M
Last round
—

Who backs Shinobi Therapeutics?

10 investors
InvestorType
Mitsubishi UFJ CapitalOther
F-Prime CapitalVenture capital
Eight RoadsAsset manager
JIC Venture Growth InvestmentsVenture capital
Kyoto University Innovation CapitalVenture capital
EQT Life SciencesVenture capital
Astellas Venture ManagementOther
D3 (Tokyo)—
Fast Track Initiative—
Yosemite—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Shinobi Therapeutics investors

10 investors are on record for Shinobi Therapeutics, including Mitsubishi UFJ Capital, F-Prime Capital, Eight Roads and JIC Venture Growth Investments. By type, the record holds 4 venture capital firms and 1 asset manager.

Free account
More of Shinobi Therapeutics with a free account
  • ·Watch Shinobi Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Shinobi Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View